Holmium-166 Transarterial Radioembolization for the Treatment of Intrahepatic Cholangiocarcinoma: A Case Series.

Authors: Vermeulen, Sim^1,2 (AUTHOR) sim.vermeulen@asz.be, De Keukeleire, Katrien³ (AUTHOR) katrien.dekeukeleire@asz.be, Dorny, Nicole^1,2 (AUTHOR) victor.nuttens@olvz-aalst.be, Colle, Isabelle⁴ (AUTHOR) isabelle.colle@asz.be, Van Den Bossche, Bert⁵ (AUTHOR) bert.vandenbossche@asz.be, Nuttens, Victor^1,2 (AUTHOR) dirk.ooms@olvz-aalst.be, Ooms, Dirk^1,2 (AUTHOR) pieter.de.bondt@olvz-aalst.be, De Bondt, Pieter^1,2 (AUTHOR) olivier.de.winter@olvz-aalst.be, De Winter, Olivier^1,2 (AUTHOR)

Source: Cancers. Oct2023, Vol. 15 Issue 19, p4791. 10p.

Subject Terms: *LIVER tumors, *CHOLANGIOCARCINOMA, *RADIOEMBOLIZATION, *RETROSPECTIVE studies, *CHEMICAL elements, *TREATMENT effectiveness, *CASE studies, *QUALITY of life, *ADVERSE health care events, *PATIENT safety

Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome.

Authors: Vermeulen, Sim¹ sim.vermeulen@uzbrussel.be, Awada, Gil¹ gil.awada@uzbrussel.be, Keyaerts, Marleen¹ marleen.keyaerts@uzbrussel.be, Neyns, Bart¹ Bart.Neyns@uzbrussel.be, Everaert, Hendrik¹ hendrik.everaert@uzbrussel.be

Source: Current Oncology. Jun2021, Vol. 28 Issue 3, p1630-1640. 11p.

Subject Terms: *MELANOMA, *DRUG side effects, *IMMUNE checkpoint inhibitors, *PEMBROLIZUMAB

Corpus Cavernosum Abscess Diagnosed on FDG PET/CT

Authors: Vermeulen, Sim, Walgraeve, Natascha, De Geeter, Frank

Source: Clinical nuclear medicine. 45(2):131-132

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100096785995.0x000001&indx=1&recIds=ETOCvdc_100096785995.0x000001

¹⁸F-FDG PET/CT in Waldenström associated amyloidosis.

Authors: De Mey, Lynn, Vermeulen, Sim, Bourgeois, Sophie, Goethals, Lode, De Geeter, Frank

Source: Hellenic Journal of Nuclear Medicine; Jan-Apr2023, Vol. 26 Issue 1, p70-72, 3p

A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab.

Authors: Awada, Gil, Jansen, Yanina, Schwarze, Julia Katharina, Tijtgat, Jens, Hellinckx, Lennert, Gondry, Odrade, Vermeulen, Sim, Warren, Sarah, Schats, Kelly, van Dam, Pieter-Jan, Kockx, Mark, Keyaerts, Marleen, Everaert, Hendrik, Seremet, Teofila, Rogiers, Anne, Neyns, Bart

Source: Cancers; Jan2021, Vol. 13 Issue 2, p168-168, 1p

Subject Terms: THERAPEUTIC use of monoclonal antibodies, ACADEMIC medical centers, DEOXY sugars, EXTRACELLULAR space, GENE expression, IMMUNOTHERAPY, LACTATE dehydrogenase, EVALUATION of medical care, MELANOMA, MULTIVARIATE analysis, NUCLEIC acids, RADIOPHARMACEUTICALS, TUMOR markers, PROPORTIONAL hazards models, GENE expression profiling